EUVIMEDEUVIMED entdecken
EditorialOpen Access · CC BY-NC 4.0

SGLT2 Inhibitors in Transthyretin Amyloid Cardiomyopathy: A Promising Signal, but Not Yet the Final Word

Darae Kim iD

International Journal of Heart Failure · 2026 · 8 (2) · 169

DOI: 10.36628/ijhf.2026.0045 ↗

Kurz gefasst

Editorial in der Zeitschrift International Journal of Heart Failure, 2026. Verfasst von Darae Kim. Beteiligte Einrichtung: Division of Cardiology, Department of Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, …. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ATTR-CM, they examined whether SGLT2i therapy was associated with improved clinical outcomes. Using a propensity score-matched design, they identified 27 treated and 27 untreated patients with balanced baseline characteristics. In this matched cohort, SGLT2i treatment was associated with a significantly lower risk of all-cause mortality. Importantly, the signal remained consistent in sensitivity analyses using treatment as a time-varying covariate, an approach specifically intended to mitigate immortal time bias.

Autor:innen und Institutionen

  • Division of Cardiology, Department of Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

ORCID-Profile: Darae Kim

Zitieren

APA

Kim, D. (2026). SGLT2 Inhibitors in Transthyretin Amyloid Cardiomyopathy: A Promising Signal, but Not Yet the Final Word. International Journal of Heart Failure, 8(2), 169. https://doi.org/10.36628/ijhf.2026.0045

Vancouver

Kim D. SGLT2 Inhibitors in Transthyretin Amyloid Cardiomyopathy: A Promising Signal, but Not Yet the Final Word. International Journal of Heart Failure. 2026;8(2):169. doi:10.36628/ijhf.2026.0045

BibTeX
@article{Kim2026,
  author = {Kim, Darae},
  title = {SGLT2 Inhibitors in Transthyretin Amyloid Cardiomyopathy: A Promising Signal, but Not Yet the Final Word},
  journal = {International Journal of Heart Failure},
  year = {2026},
  volume = {8},
  number = {2},
  pages = {169},
  doi = {10.36628/ijhf.2026.0045}
}
Kostenlos starten →